Conference
A phase III adjuvant trial of sequenced EC plus filgrastim plus epoetin-alpha followed by paclitaxel compared to sequenced AC followed by paclitaxel compared to CEF in women with node-positive or high-risk node-negative breast cancer (NCIC CTG MA.21)
Authors
Burnell MJ; Levine MN; Chapman JA; Bramwell V; Vandenberg T; Chalchal HI; Albain K; Perez E; Rugo H; Pritchard K
Volume
25
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
June 20, 2007
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
18
ISSN
0732-183X